Graves病的<sup>131</sup>I治疗和抗甲状腺药物治疗:随机对照试验荟萃分析

赵炎; 王俊起; 沈婕; 赵炎; 王俊起; 沈婕

doi:10.3760/cma.j.issn.1673-4114.2017.06.003

[1]

Cooper GS, Stroehla BC. The epidemiologyof autoimmune discase[J]. Autoimmun Rev, 2003, 2(3):119-125. DOI:http://dx.doi.org/10.1016/Sl568-9972(03)00006-5.

[2]

Abraham-Nordling M, Byström K, Törring O, et al. Incidence of hyperthyroidism in Sweden[J]. Eur J Endocrinol, 2011, 165(6):899-905. DOI:10.1530/EJE-11-0548.

[3]

Menconi F, Marcocci C, Marinò M. Diagnosis and classification of Graves' disease[J]. Autoimmun Rev, 2014, 13(4-5):398-402. DOI:10.1016/j.autrev.2014.01.013.

[4]

Wartofsky L, Glinoer D, Solomon B, et al. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States[J]. Thyroid, 1991, 1(2):129-135. DOI:10.1089/thy.1991.1.129.

[5]

Solomon B, Glinoer D, Lagasse R, et al. Current trends in the management of Graves' disease[J]. J Clin Endocrinol Metab, 1990, 70(6):1518-1524. DOI:10.1210/jcem-70-6-1518.

[6]

Prummel MF, Wiersinga WM, Mourits MP, et al. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy[J]. Arch Intern Med, 1990, l50(5):1098-1101. DOI:10.1001/archinte.1990. 00390170124027.

[7]

Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials:is blinding necessary?[J]. Control Clin Trials, 1996, 17(1):1-12. DOI:10.1016/0197-2456(95)00134-4.

[8]

Abraham-Nordling M, Wallin G, Träisk F, et al. Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine[J]. Eur J Endocrinol, 2010, 163(4):651-657. DOI:10.1530/EJE-10-0475.

[9]

Azizi F, Ataie L, Hedayati M, et al. Effect of long-term continuous methimazole treatment of hyperthyroidism:comparison with radioiodine[J]. Eur J Endocrinol, 2005, 152(5):695-701. DOI:10.1530/eje.1.01904.

[10]

Kung AW, Yau CC, Cheng A. The incidence of ophthalmopathy after radioiodine therapy for Graves' disease:prognostic factors and the role of methimazole[J]. J Clin Endocrinol Metab, 1994, 79(2):542-546. DOI:10.1210/jcem.79.2.7913934.

[11]

Kung AW, Yau CC, Cheng AC. The action of methimazole and L-thyroxine in radioiodine therapy:a prospective study on the incidence of hypothyroidism[J]. Thyroid, 1995, 5(1):7-12. DOI:10.1089/thy.1995.5.7.

[12]

Tallstedt L, Lundell G, Tørring O, et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group[J]. N Engl J Med, 1992, 326(26):1733-1738. DOI:10.1056/NEJM199206253262603.

[13]

Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy[J]. N Engl J Med, 1998, 338(2):73-78. DOI:10.1056/NEJM199801083380201.

[14]

赵伟平. 甲状腺功能亢进应用他巴唑和放射性¹³¹I治疗的对比评估及分析[J/OL]. 世界最新医学信息文摘(连续型电子期刊), 2015, 15(83): 102-103[2017-09-01]. http://new.wanfangdata.com.cn/details/detail.do?_type=perio&id=sjzxyy-e201583074. DOI: 10.3969/j.issn.1671-3141.2015.83.074.

Zhao WP. Effect comparison of tapazole versus radioiodine therapy in the treatment of patients with Graves hyperthyroidism[J/OL]. World Latest Med Inform, 2015, 15(83):102-103[2017-09-01]. http://new.wanfangdata.com.cn/details/detail.do?_type=perio&id=sjzxyy-e201583074.

[15]

叶惠成. ¹³¹I与抗甲状腺药物治疗300例甲亢患者疗效分析[J].中国医学工程, 2015, 23(11):163-164.
Ye HC. Treatment analysis of ¹³¹I and ATD in 300 patients with Graves' disease. China Med Eng, 2015, 23(11):163-164.

[16]

黄诚, 李玮, 胡斌, 等. ¹³¹I与抗甲状腺药物治疗Graves甲亢的疗效评价[J].陕西医学杂志, 2009, 38(6):676-677. DOI:10.3969/j.issn.1000-7377.2009.06.013.
Huang C, Li W, Hu B, et al. The curative effects of ¹³¹I and ATD for patients with Graves hyperthyroidism[J]. Shaanxi Med J, 2009, 38(6):676-677. doi: 10.3969/j.issn.1000-7377.2009.06.013

[17]

刘艳, 付立武, 魏月芳, 等. ¹³¹I与抗甲状腺药物治疗Graves甲亢的疗效评价[J].河南科技大学学报(医学版), 2008, 26(4):265-266. DOI:10.3969/j.issn.1672-688X.2008.04.011.
Liu Y, Fu LW, Wei YF, et al. Curative effect evaluation of ¹³¹I and ATD therapy for patients with Graves' hyperthyroidism[J]. J Henan Univ Sci Tech(Med Sci), 2008, 26(4):265-266. doi: 10.3969/j.issn.1672-688X.2008.04.011

[18]

陈丹云, 陈棠华. ¹³¹I与抗甲状腺药物治疗儿童Graves病的疗效对照研究[J].中华儿科杂志, 2005, 43(7):507-509. DOI:10.3760/j.issn:0578-1310.2005.07.007.
Chen DY, Chen TH. Comparison of the effectiveness of ¹³¹I and antithyroid drugs in the treatment of Graves' disease in children[J]. Chin J Pediatr, 2005, 43(7):507-509. doi: 10.3760/j.issn:0578-1310.2005.07.007

[19]

陶黎莉. ¹³¹I与抗甲状腺药物治疗甲亢的疗效比较[J].中国现代药物应用, 2015, 9(21):151-152. DOI:10.14164/j.cnki.cn11-5581/r.2015.21.111.
Tao LL. Compaison of efficacy of ¹³¹I and antithyroid drugs in the treatment of Graves' disease[J]. Chin J Mod Drug Appl, 2015, 9(21):151-152. doi: 10.14164/j.cnki.cn11-5581/r.2015.21.111

[20]

徐波, 黄辉, 邝继文. ¹³¹I与抗甲状腺药物治疗甲亢的疗效比较[J].中国热带医学, 2006, 6(11):2041-2042. DOI:10.3969/j.issn.1009-9727.2006.11.067.
Xu B, Huang H, Kuang JW. Comparative study on the therapeutic effect of ¹³¹I and anti-thyroidism drugs on hyperthyroidism[J]. China Trop Med, 2006, 6(11):2041-2042. doi: 10.3969/j.issn.1009-9727.2006.11.067

[21]

杨秀真. ¹³¹I与抗甲状腺药物治疗甲亢的疗效比较[J].中国药师, 2009, 12(9):1283-1284. DOI:10.3969/j.issn.1008-049X.2009.09. 052.
Yang XZ. Therapeutic effect comparison of ¹³¹I and anti-thyroid drugs on patients with hyperthyroidism[J]. China Pharmacist, 2009, 12(9):1283-1284. doi: 10.3969/j.issn.1008-049X.2009.09.052

[22]

邓豪余, 梁昌华, 肖敏, 等. 131碘、抗甲状腺药物及手术治疗Graves甲亢的比较[J].中国现代医学杂志, 2003, 13(2):24-27. DOI:10.3969/j.issn.1005-8982.2003.02.009.
Deng HY, Liang CH, Xiao M, et al. Comparison of ¹³¹I, ATD and surgica1 treatment in the Graves hyperthyroidism patients[J]. China J Mod Med, 2003, 13(2):24-27. doi: 10.3969/j.issn.1005-8982.2003.02.009

[23]

李三喜. 131 I与抗甲状腺药物治疗甲状腺机能亢进症的疗效比较[J].西南军区, 2010, 12(6):1051-1052. DOI:10.3969/j.issn.1672-7193. 2010. 06.006.
Li SX. Comparison between the curative effects of ¹³¹I and antithyroid drugs on hyperthy-roidism[J]. J Mil Surgeon Southwest China, 2010, 12(6):1051-1052. doi: 10.3969/j.issn.1672-7193.2010.06.006

[24]

葛冉. ¹³¹I与抗甲状腺药物在甲状腺机能亢进症治疗中的应用及比较[J].吉林医学, 2015, 36(12):2065. DOI:10.3969/j.issn.1004-0412.2015.12.115.
Ge R. Effects comparison between the curative effects of ¹³¹I and anti-thyroid drugs on hyperthyroidism[J]. Jilin Med J, 2015, 36(12):2065. doi: 10.3969/j.issn.1004-0412.2015.12.115

[25]

Acharya SH, Avenell A, Philip S, et al. Radioiodine therapy(RAI) for Graves' disease(GD) and the effect on ophthalmopathy:a systematic review[J]. Clin Endocrinol (Oxf), 2008, 69(6):943-950. DOI:10.1111/j.1365-2265.2008.03279.x.

[26]

Ren Z, Qin L, Wang JQ, et al. Comparative Efficacy of Four Treatments in Patients with Graves' Disease:a Network Meta-analysis[J]. Exp Clin Endocrinol Diabetes, 2015, 123(5):317-322. DOI:10.1055/s-0035-1548824.